OCGN peer analysis
Ocugen (OCGN) against its competitors: price, today's move, 1-year return and market value side by side.
OCGN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADCT ADC Therapeutics | $1.34 | -4.96% | -66.91% | $171.07M |
| ALMS Alumis | $5.58 | -8.89% | 6.58% | $722.90M |
| CMPX Compass Therapeutics | $0.77 | -5.84% | -84.24% | $139.05M |
| FULC Fulcrum Therapeutics | $3.77 | 2.58% | -54.84% | $288.02M |
| LCTX Lineage Cell Therapeutics | $0.91 | -8.11% | -52.85% | $230.15M |
| LXRX Lexicon Pharmaceuticals | $1.80 | -1.10% | 16.88% | $801.42M |
| NGNE Neurogene | $23.98 | 0.31% | -22.86% | $496.30M |
| NMRA Neumora Therapeutics | $0.43 | -8.46% | -84.86% | $81.36M |
| OMER Omeros | $17.49 | -2.78% | 153.85% | $1.27B |
| OCGN Ocugen | $0.83 | -5.24% | -38.22% | $280.88M |
- OCGN's peers: ADCT (ADC Therapeutics), ALMS (Alumis), CMPX (Compass Therapeutics), FULC (Fulcrum Therapeutics), LCTX (Lineage Cell Therapeutics), LXRX (Lexicon Pharmaceuticals), NGNE (Neurogene), NMRA (Neumora Therapeutics).
Updated 2026-11-14 00:53 UTC